
Cognet S 250mg/125mg Injection
Marketer
Sparkles Exim Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cognet S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be strictly under medical guidance; missed doses should be avoided, and the prescribed treatment course completed fully, even with symptom improvement. Premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate consultation. Seek immediate medical attention for allergic reactions such as rashes, itching, swelling, or respiratory distress. Disclose all current medications to your physician prior to commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption is discouraged due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, proper nutrition, and ample hydration contribute to faster recovery. Your doctor may order tests to monitor the medication's impact.
Uses of Cognet S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cognet S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cognet S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cognet S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cognet S 250mg/125mg Injection works:
Cognet S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, combines an antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby improving Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Cognet S 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cognet S (250mg/125mg) is usually deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Cognet S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Cognet S 250mg/125mg Injection can lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cognet S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Administering Cognet S 250mg/125mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alterations for Cognet S 250mg/125mg Injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cognet S 250mg/125mg Injection :
Should you inadvertently omit a dose of Cognet S 250mg/125mg Injection, seek medical advice.
Facts to Know About Cognet S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
